San Antonio Kidney Disease Center Ph is categorized under Unclassified in Floresville, TX and active since 2010.
San Antonio Kidney Disease Center Ph was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Unclassified business, which does work in the B2B market, and is classified as a Unclassified, under code number 561990 by the NAICS.
If you are seeking more information, feel free to contact John Frierson at the company’s single location by writing to 1303 Hospital Boulevard, Floresville, Texas TX 78114 or by phoning (830) 216-2907. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | San Antonio Kidney Disease Center Ph |
| Contact Person: | John Frierson |
| Address: | 1303 Hospital Boulevard, Floresville, Texas 78114 |
| Phone Number: | (830) 216-2907 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Unclassified |
| SIC Code: | 7389 |
| NAICS Code: | 561990 |
| Share This Business: |
San Antonio Kidney Disease Center Ph was started in 2010 to provide professional Unclassified under the SIC code 7389 and NAICS code 561990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact John Frierson for inquiries that concern San Antonio Kidney Disease Center Ph by calling the company number (830) 216-2907, as your correspondence is most welcome. Additionally, the physical location of the single location of San Antonio Kidney Disease Center Ph can be found at the coordinates 29.129776,-98.149902 as well as the street address 1303 Hospital Boulevard in Floresville, Texas 78114.
For its online presence, you may visit San Antonio Kidney Disease Center Ph’s website at and engage with its social media outlets through on Twitter and on Facebook.